CDC Releases “Dear Provider” Letter to Clarify Measles Recommendations

The CDC released a new “Dear Provider” letter this month to clarify adult MMR recommendations and immunity questions.  In the letter, the CDC states: Providers do not need to actively screen adult patients for measles immunity.  This is because of high population immunity and low risk of disease among adults in non-outbreak areas in the […]

FDA Approves New Flu Drug

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of acute uncomplicated influena (flu).  Xofluza (baloxavir marboxil) was approved this week for patients 12 years and older who have been symptomatic for less than 48 hours. “This is the first new antiviral flu treatment with a novel mechanism of […]